NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 12 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,536,000 | -22.7% | 3,004,000 | -7.7% | 0.11% | -28.7% |
| Q4 2020 | $5,865,000 | +19.4% | 3,254,000 | 0.0% | 0.15% | +2.7% |
| Q3 2020 | $4,914,000 | +6.5% | 3,254,000 | -3.7% | 0.15% | -0.7% |
| Q2 2020 | $4,616,000 | +28.1% | 3,380,000 | +12.7% | 0.15% | +15.7% |
| Q1 2020 | $3,604,000 | -36.1% | 3,000,000 | -27.6% | 0.13% | -20.6% |
| Q4 2019 | $5,638,000 | -17.3% | 4,144,000 | -30.9% | 0.16% | -23.1% |
| Q3 2019 | $6,816,000 | +9.1% | 5,994,000 | 0.0% | 0.21% | +7.8% |
| Q2 2019 | $6,248,000 | +3.4% | 5,994,000 | +0.1% | 0.19% | -0.5% |
| Q1 2019 | $6,045,000 | +8.9% | 5,990,000 | +0.0% | 0.19% | -4.9% |
| Q4 2018 | $5,553,000 | -14.6% | 5,988,000 | -8.6% | 0.20% | +13.3% |
| Q3 2018 | $6,502,000 | +32.6% | 6,551,000 | +45.6% | 0.18% | +26.8% |
| Q2 2018 | $4,905,000 | +70.5% | 4,500,000 | +80.0% | 0.14% | +46.4% |
| Q1 2018 | $2,877,000 | -8.1% | 2,500,000 | -16.7% | 0.10% | -8.5% |
| Q4 2017 | $3,129,000 | +31.7% | 3,000,000 | +50.0% | 0.11% | +24.7% |
| Q3 2017 | $2,376,000 | +10.8% | 2,000,000 | 0.0% | 0.08% | +6.2% |
| Q2 2017 | $2,144,000 | +299.3% | 2,000,000 | +292.2% | 0.08% | +321.1% |
| Q2 2016 | $537,000 | – | 510,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|